eNewsroom for: Invivotek

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/Invivotek/Screen-Shot-2013-11-19-at-4.45.05-PM.png

Invivotek Company Profile

Invivotek™ is a member of the Genesis Biotechnology Group™ (GBG), a consortium of vertically integrated entities pursuing clinical diagnostic testing, preclinical and translational research, and the manufacturing and distribution of life science products. GBG’s combined research scientific community creates and sustains drug development and diagnostic programs for targeting infectious, metabolic, inflammatory, and autoimmune diseases, as well as cancer and other issues relating to women’s health.

News from Invivotek:

Invivotek Awarded Full AAALAC Accreditation for Excellence in Laboratory Animal Care and Use

HAMILTON, N.J., July 14, 2014 /PRNewswire/ – Invivotek L.L.C., a member of the Genesis Biotechnology Group, LLC is pleased to announce that its animal research facility was awarded full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care Inter…

Invivotek Receives Distinguished Innovation and Achievement Award from Allentown, Inc., the Leader in Design and Installation for Quality Animal Housing

HAMILTON, N.J., Nov. 20, 2013 /PRNewswire/ – Invivotek, LLC is the proud recipient of the Innovation and Achievement Award recognizing excellence in animal facility design, planning, construction and operation. The Award was presented by Allentown, Inc., a leader in design and installati…